New Oral Selective Estrogen Receptor Degraders Redefine Management of Estrogen Receptor–Positive Breast Cancer

Pathak, Neha; Oliveira, Mafalda

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Pathak, Neha
dc.contributor.author	Oliveira, Mafalda
dc.date.accessioned	2025-03-20T10:44:08Z
dc.date.available	2025-03-20T10:44:08Z
dc.date.issued	2025
dc.identifier.citation	Pathak N, Oliveira M. New Oral Selective Estrogen Receptor Degraders Redefine Management of Estrogen Receptor–Positive Breast Cancer. Annu Rev Med. 2025 Jan;76:243–55.
dc.identifier.issn	1545-326X
dc.identifier.uri	http://hdl.handle.net/11351/12794
dc.description	Cáncer de mama; Camizestrant; Receptor de estrógeno
dc.language.iso	eng
dc.publisher	Annual Reviews
dc.relation.ispartofseries	Annual Review of Medicine;76
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Estrògens - Antagonistes - Ús terapèutic
dc.subject	Antihormones - Ús terapèutic
dc.subject	Mama - Càncer - Tractament
dc.subject	Medicaments antineoplàstics - Ús terapèutic
dc.subject.mesh	Selective Estrogen Receptor Modulators
dc.subject.mesh	/therapeutic use
dc.subject.mesh	Breast Neoplasms
dc.subject.mesh	/drug therapy
dc.subject.mesh	Antineoplastic Agents, Hormonal
dc.subject.mesh	Estrogen Receptor Antagonists
dc.subject.mesh	/therapeutic use
dc.title	New Oral Selective Estrogen Receptor Degraders Redefine Management of Estrogen Receptor–Positive Breast Cancer
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1146/annurev-med-052423-122001
dc.subject.decs	moduladores selectivos de los receptores de estrógenos
dc.subject.decs	/uso terapéutico
dc.subject.decs	neoplasias de la mama
dc.subject.decs	/farmacoterapia
dc.subject.decs	antineoplásicos hormonales
dc.subject.decs	antagonistas de receptores estrogénicos
dc.subject.decs	/uso terapéutico
dc.relation.publishversion	https://doi.org/10.1146/annurev-med-052423-122001
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Pathak N] Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. [Oliveira M] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid	39869433
dc.rights.accessrights	info:eu-repo/semantics/openAccess